These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 5955405)

  • 21. [Clinical trial of a new cardiac glycoside: cd.412].
    Gentile C; Gentile JH
    Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118
    [No Abstract]   [Full Text] [Related]  

  • 22. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peculiarities of cardiac glycoside therapy in the aged].
    Erdmann E
    Internist (Berl); 1991 Aug; 32(8):472-8. PubMed ID: 1938268
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiac dynamics-quotient and glycoside therapy].
    Gutschker A
    Dtsch Gesundheitsw; 1970 Aug; 25(32):1515-6. PubMed ID: 5509390
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic experiences with proscillaridin A in decompensated heart diseases].
    Verga L; Forzani GF
    Minerva Med; 1967 Dec; 58(96):4318-22. PubMed ID: 6083293
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
    Neumann H
    Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
    [No Abstract]   [Full Text] [Related]  

  • 27. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
    Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
    Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modifying factors in carciac glycoside therapy].
    Krebs R
    Med Klin; 1976 Oct; 71(42):1759-70. PubMed ID: 790134
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
    Grujić M; Perinović M; Ljubojević S
    Med Arh; 1977; 31(3):171-5. PubMed ID: 333198
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experience with the new cardiac glycoside peruvosid].
    Pfund WD
    Hippokrates; 1969 Aug; 40(16):646-53. PubMed ID: 5810178
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
    Hansel J
    Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
    [No Abstract]   [Full Text] [Related]  

  • 32. [Home treatment of patients with chronic cardiac insufficiency].
    Sviridov AM; Nikitina VG
    Voen Med Zh; 1970 Mar; 3():41-4. PubMed ID: 5445263
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the problem of the method of prolonged use of cardiac glycosides in patients with mitral defects and chronic circulatory insufficiency].
    Kats GL
    Sov Med; 1967 Apr; 30(4):79-83. PubMed ID: 5608582
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
    Sorrentino F; Musco A; Cascone O; Modica G
    Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470
    [No Abstract]   [Full Text] [Related]  

  • 35. [Individual glycoside therapy using serum concentration determination in canine heart failure].
    Staudacher G
    Dtsch Tierarztl Wochenschr; 1989 May; 96(6):308-10. PubMed ID: 2758985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiotonic effect of Cd 412 (Peruvosid) on normal humans and subjects with cardiac insufficiency].
    Rivara Ruiz G; Dejo Bustios G; Alvarez Molteni R
    Rev Esp Cardiol; 1971; 24(2):191-9. PubMed ID: 4944701
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications and contraindications for therapy with cardiac glycosides].
    Haasis R
    Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of cardiac insufficiency with prosillaridin with special reference to chronic pulmonary heart disease].
    Ramsthaler D; Ramsthaler B
    Med Welt; 1969 Dec; 52():2809-11. PubMed ID: 5392715
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Digitalis in the therapy of cardiac insufficiency].
    Weinbergová O
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():193-201. PubMed ID: 2530816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.